We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

161 hedge funds and large institutions have $176M invested in Heron Therapeutics in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 51 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,109% more call options, than puts

Call options by funds: $4.61M | Put options by funds: $64K

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4.75% less ownership

Funds ownership: 80.32% → 75.57% (-4.8%)

7% less funds holding

Funds holding: 173 → 161 (-12)

18% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 51

26% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 35

27% less capital invested

Capital invested by funds: $242M → $176M (-$66.6M)

Holders
161
Holders Change
-12
Holders Change %
-6.94%
% of All Funds
2.12%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
42
Reduced
51
Closed
35
Calls
$4.61M
Puts
$64K
Net Calls
+$4.55M
Net Calls Change
+$4.47M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.99M
2
Morgan Stanley
Morgan Stanley
New York
+$1.66M
3
SCM
Stonepine Capital Management
Oregon
+$1.13M
4
CPC
Congress Park Capital
New York
+$774K
5
QOP
Quinn Opportunity Partners
Virginia
+$616K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$2.58M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2.28M
3
Goldman Sachs
Goldman Sachs
New York
-$1.71M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.33M
5
N
Nuveen
North Carolina
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFO
151
Fortitude Family Office
Arizona
$430 – – –
PA
152
Parallel Advisors
California
$306 – – –
EBA
153
Eagle Bay Advisors
New York
$295 – – –
CA
154
CoreCap Advisors
Michigan
$271 +$287 +177 New
GM
155
GeoWealth Management
Illinois
$265 -$2.09K -1,291 -88%
PNC Financial Services Group
156
PNC Financial Services Group
Pennsylvania
$179 – – –
AF
157
Advisornet Financial
Minnesota
$168 – – –
Nisa Investment Advisors
158
Nisa Investment Advisors
Missouri
$153 -$172 -106 -51%
EWM
159
Evermay Wealth Management
Virginia
$153 – – –
IA
160
IFP Advisors
Florida
$54 +$57 +35 New
EWA
161
EverSource Wealth Advisors
Alabama
$50 +$53 +33 New
Citadel Advisors
162
Citadel Advisors
Florida
– -$2.58M -1,591,547 Closed
Qube Research & Technologies (QRT)
163
Qube Research & Technologies (QRT)
United Kingdom
– -$2.28M -1,146,658 Closed
Squarepoint
164
Squarepoint
New York
– -$1.22M -612,897 Closed
GCP
165
GSA Capital Partners
United Kingdom
– -$1.02M -512,736 Closed
ZIM
166
Zacks Investment Management
Illinois
– -$946K -475,575 Closed
HF
167
HRT Financial
New York
– -$849K -426,817 Closed
KBC Group
168
KBC Group
Belgium
– -$576K -289,269 Closed
Federated Hermes
169
Federated Hermes
Pennsylvania
– -$221K -110,914 Closed
GC
170
Grimes & Company
Massachusetts
– -$95.2K -47,863 Closed
Prudential Financial
171
Prudential Financial
New Jersey
– -$84.6K -42,515 Closed
HS
172
Horan Securities
United States
– -$58.3K -29,310 Closed
FWP
173
Firethorn Wealth Partners
Georgia
– -$51.8K -26,013 Closed
Bank of Montreal
174
Bank of Montreal
Ontario, Canada
– -$50.1K -25,194 Closed
DWM
175
Dakota Wealth Management
Florida
– -$47.7K -23,950 Closed
4 5 6
7
8

HRTX Hedge Fund Activity: Q4 2024 in Review

161 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2024, worth a combined $176M — down 27% from $242M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of HRTX and 26 opened new positions — a net loss of 9 holders — while 51 trimmed existing stakes and 42 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $4.99M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.58M sold.

  • 161 institutional investors held Heron Therapeutics (HRTX) as of Q4 2024, down from 173 in Q3 2024.
  • Funds reported $176M of Heron Therapeutics stock for Q4 2024, down 27% quarter-over-quarter.
  • 26 funds opened new Heron Therapeutics positions in Q4 2024 and 35 closed out, a net change of -9 holders.
  • The largest Heron Therapeutics buyer in Q4 2024 was Point72 Asset Management, an estimated $4.99M added.
  • The largest Heron Therapeutics seller in Q4 2024 was Citadel Advisors, an estimated $2.58M sold.

Based on aggregated 13F filings for Q4 2024.